|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | p16 inactivation by methylation of the CDKN2A promoter occurs early during neoplastic progression in Barrett, s esophagus显示文摘 | BIAN YS OSTERHELD MC FONTOLLIET C | 2002 | Gastroenterollogy2002，22，11： | 1 |
| 2 | p16 inactivation by methylation of the CDKN2A promoter occurs early during neoplastic progression in Barrett's esophagus显示文摘 | Bian Y S Osterheld M C Fontolliet C | 2002 | Gastroenterology2002，122，4： | 1 |
| 3 | p16inactivation bymethylation of the GDKN2A promoter occurs early duringneop1astic pmgression in Barrett’s esophagus显示文摘 | Bian YS Osterheld MC Fontolliet C | 2002 | Gastroente-rology2002，122，4： | 1 |
| 4 | The natural history,prevalence and incidence of reflux esophagitis显示文摘 | Olly JB Monnier P Fontolliet C | 1993 | Gut1993，34，2： | 1 |
| 5 | Photodynamic therapy for 101 early cancers of the upper aerodigestive tract,the esophagus,and the bronchi:a single-institution experience显示文摘 | Radu A Grosjean P Fontolliet C | | 0，，03： | 1 |
| 6 | p16 inactivation by methylation of the CDKN2A promoter, occur early during neoplastic progression in Barrett, sesophagus显示文摘 | Bian YS Osterheld MC Fontolliet C | 2002 | Gastroenterology2002，22，4： | 1 |
| 7 | External iliac artery dissection due to fibromusctUar dysplasia显示文摘 | Burri B Fontolliet C Ruegsegger CH | 1983 | Vssa1983，12，1： | 1 |
| 8 | p16 inactivation by methylation of the CDKN2A promoter occurs early during neoplastic progression in Barrett's esophagus 显示文摘 | Bian YS Osterheld MC Fontolliet C | 2002 | Gastroenterology2002，122，4： | 1 |
| 9 | Photody- namic therapy for early squamous cell carcinomas of the esopha- gus, bronchi, and mouth with m-tetra (hydroxyphenyl) hlorine 显示文摘 | SAVARY JF MONNIER P FONTOLLIET C | 1997 | Arch Otolaryngol Head Neck Surg1997，123，2： | 1 |
| 10 | Photodynamic therapy for early squamous cell carcinomas of the esophagus, bronchi, and mouth with m-tetra (hydroxyphenyl) chlorin显示文摘 | Savary IF Monnier P Fontolliet C | 1997 | Arch Otolaryn- gol Head Neck Surg1997，123，2： | 1 |
| 11 | Photodynamic therapy for 101 early cancers of the upper aerodigestive tract, the esophagus, and the bronchi : a single-institution experience 显示文摘 | Radu A Gmsjean P Fontolliet C | 1999 | Diagn Ther Endosc1999，5，3： | 1 |
| 12 | Therapeutic potential of the anti-angiogenesis drugs TNP-470显示文摘 | Gervaz P Fontolliet C | 1998 | Int J Exp Pathol1998，79，6： | 1 |
| 13 | p16 inactivation by methylation of the CDKN2A promoter Occurs early during neoplastic progression in Barreffs esophagus显示文摘 | Bian YS Osterheld MC Fontolliet C | 2002 | Gastroenterology2002，22，4： | 1 |
| 14 | p16 inactivation by methylation of the CDKN2A promoter occurs early during neoplastic progression in Barrett's esophagus显示文摘 | Bian Y S Osterheld M C Fontolliet C | 2002 | Gastroenterology2002，122，4： | 1 |
| 15 | p16 inactivation by methylation of the GDKN2A promoter occurs early during neoplastic progression in Barrett's esophagus显示文摘 | Bian YS Osterheld MC Fontolliet C | 2002 | Gastrocnterol-ogy2002，122，4： | 1 |
| 16 | Photodynamic therapy for 101 early cancers of the upper aerodigestive tract, the esophagus, and the bronchi: a single-institution experience 显示文摘 | Radu A Grosjean P Fontolliet C | 1999 | Diagn Ther Endosc1999，5，3： | 1 |
| 17 | Photodynamic therapy of early squamous cell carcinomas of the eosophagus: a review of 31 cases显示文摘 | Monnier P Fontolliet C | 1998 | Endoscopy1998，30，： | 1 |
| 18 | p16 inactivation by methylation of the CDKN2A promoter occurs early during neoplastic progression in Barrett's esophagus显示文摘 | Bian YS Osterheld MC Fontolliet C | | 0，，： | 1 |
| 19 | Therapeutic potential of theanti-angiog-enesis drug TNP-470显示文摘 | fontolliet C | 1998 | Int J Exp Pathol1998，79，6： | 1 |
| 20 | Photodynamic therapy for 101 early cancers of the upper aerodigestive tract,the esophagus,and the bronchi:a single-institution experience显示文摘 | Radu A Grosjean P Fontolliet C | 1999 | Diagn Ther Endosc1999，5，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员